Business Intelligence & Development
STCC's industry partnership gateway for oncology research in Singapore.
Last updated 13 July 2026
The Business Intelligence and Development (BID) platform is STCC's dedicated gateway for industry engagement — a single point of contact connecting pharmaceutical, biotechnology, healthcare, and research organisations to oncology clinical research and collaborative trials opportunities in Singapore.
Through strategic partnership development and business intelligence, BID matches industry priorities with STCC's clinical and research expertise to facilitate collaborative cancer trials, translational research initiatives, and innovative study partnerships. By connecting academic, clinical, and industry stakeholders, BID helps accelerate research, advance cancer care, and create pathways for clinical and commercial impact.
How BID Supports Partners
Connect pharmaceutical, biotech and healthcare partners with early-stage innovation opportunities across academia and industry
Facilitate collaborative cancer trials and research studies with STCC's network of clinician-scientists and researchers
Unlock access to global academic and industry networks to expand research opportunities and accelerate development
Partnership opportunities
Interested in collaborating on projects or exploring partnership opportunities? Share your details via our online form.